This dual-action medication represents a significant advancement in pharmacotherapy for metabolic conditions
It works by slowing down how fast food leaves your stomach
But theres a fine linewhile mild nausea can be tolerated and even beneficial, we dont want it to become debilitating
Summary: This phase 2 trial, a precursor to the phase 3 studies, provided the initial evidence for the superior efficacy of the CagriSema combination
10.7150/ijbs.41852 Summary Keywords glutathione S-transferase mu-3, pancreatic cancer, proliferation, ROS, glycolysis Citation Wang S, Yang J, Ding C, Li J, You L, Dai M and Zhao Y (2020) Glutathione S-Transferase Mu-3 Predicts a Better Prognosis and Inhibits Malignant Behavior and Glycolysis in Pancreatic Cancer
SURMOUNT-5 - head-to-head